William Hait Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 hours ago
William Hait has an estimated net worth of at least $16.3 million*, as of today. They own 39,074 shares of JNJ stock. They have sold 59,397 shares of JNJ stock since 2021, for an estimated $10.6 million.
William Hait $JNJ SEC Form 4 Insider Trading
William Hait has filed a total of 11 insider trades in $JNJ since 2021. Their most recent trade was a sale of 14,698 shares, made on Jul 26, 2023. Their largest trade was a sale of 22,591 shares, made on Apr 21, 2022. We estimate that they now own 39,074 shares of $JNJ, worth an estimated $5.8 million.
Insider Trading at $JNJ
There have been a total of 346 insider trades reported at $JNJ since 2021, with 0 shares purchased and 637,058 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 5,635 shares reported by Robert J Decker (VP Corporate Controller), made on Aug 30, 2024.
History of Insider Stock Trades by William Hait
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
JNJ | Sale | 14,698 | Jul 26, 2023 | July 27, 2023, 5:52 p.m. |
JNJ | Sale | 1,187 | Oct 24, 2022 | Oct. 26, 2022, 4:51 p.m. |
JNJ | Sale | 13,813 | Oct 24, 2022 | Oct. 26, 2022, 4:51 p.m. |
JNJ | Sale | 100 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 225 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 700 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 100 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 1,696 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 2,884 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 22,591 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
JNJ | Sale | 1,403 | Apr 21, 2022 | April 25, 2022, 4:33 p.m. |
$JNJ Executives and Stock Owners with Insider Trades
-
Peter Fasolo, Exec VP, Chief HR Officer
-
Thibaut Mongon, Exec VP, WW Chair, Consumer
-
William Hait, See Remarks
-
Kathryn E Wengel, EVP, Chief GSC Officer
-
Robert J Decker, Controller, CAO
-
Ashley Mcevoy, EVP, WW Chair, MedTech
-
Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals
-
Joseph J Wolk, Exec VP, CFO
-
James D. Swanson, See Remarks
-
Kathryn E Wengel, EVP, Chief TO and Risk Officer
-
Robert J Decker, VP Corporate Controller
-
Vanessa Broadhurst, EVP, Global Corp Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.